Literature DB >> 20215380

Susceptibility testing and clinical outcome in fungal keratitis.

Brett L Shapiro, Prajna Lalitha, Allison R Loh, Annette W Fothergill, Namperumalsamy V Prajna, Muthiah Srinivasan, Amit Kabra, Jaya Chidambaram, Nisha R Acharya, Thomas M Lietman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20215380     DOI： 10.1136/bjo.2009.158675

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  13 in total

Review 1.  Diagnosis of infectious diseases of the eye.

Authors:  S Sharma
Journal:  Eye (Lond)       Date:  2011-11-18       Impact factor: 3.775

2.  Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis.

Authors:  Prajna Lalitha; Brett L Shapiro; Allison R Loh; Annette W Fothergill; N Venkatesh Prajna; M Srinivasan; Catherine E Oldenburg; David A Quigley; Jaya D Chidambaram; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Br J Ophthalmol       Date:  2010-10-28       Impact factor: 4.638

3.  Natamycin and Azithromycin Are Synergistic In Vitro against Ocular Pathogenic Aspergillus flavus Species Complex and Fusarium solani Species Complex Isolates.

Authors:  Haoyi Guo; Lutan Zhou; Yi He; Chuanwen Gao; Lei Han; Yan Xu
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

4.  Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial.

Authors:  Prajna Lalitha; N Venkatesh Prajna; Catherine E Oldenburg; Muthiah Srinivasan; Tiruvengada Krishnan; Jeena Mascarenhas; C M Vaitilingam; Stephen D McLeod; Michael E Zegans; Travis C Porco; Nisha R Acharya; Thomas M Lietman
Journal:  Cornea       Date:  2012-06       Impact factor: 2.651

5.  Rifampin Enhances the Activity of Amphotericin B against Fusarium solani Species Complex and Aspergillus flavus Species Complex Isolates from Keratitis Patients.

Authors:  Yi He; Lutan Zhou; Chuanwen Gao; Lei Han; Yan Xu
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis.

Authors:  Catherine E Oldenburg; Prajna Lalitha; Muthiah Srinivasan; Palanisamy Manikandan; M Jayahar Bharathi; Revathi Rajaraman; Meenakshi Ravindran; Jeena Mascarenhas; Natalie Nardone; Kathryn J Ray; David V Glidden; Nisha R Acharya; Thomas M Lietman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-28       Impact factor: 4.799

7.  In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Authors:  Prajna Lalitha; Catherine Q Sun; N Venkatesh Prajna; Rajarathinam Karpagam; Manoharan Geetha; Kieran S O'Brien; Vicky Cevallos; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Am J Ophthalmol       Date:  2013-10-22       Impact factor: 5.258

8.  Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.

Authors:  Catherine Q Sun; Prajna Lalitha; N Venkatesh Prajna; Rajarathinam Karpagam; Manoharan Geetha; Kieran S O'Brien; Catherine E Oldenburg; Kathryn J Ray; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal:  Ophthalmology       Date:  2014-04-16       Impact factor: 12.079

9.  IL-17 produced by Th17 cells alleviates the severity of fungal keratitis by suppressing CX43 expression in corneal peripheral vascular endothelial cells.

Authors:  Xiu-Hong Qin; Xiang Ma; Shi-Feng Fang; Zhen-Zhen Zhang; Jian-Min Lu
Journal:  Cell Cycle       Date:  2019-01-20       Impact factor: 4.534

10.  Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates.

Authors:  Linu Pradhan; Savitri Sharma; Suma Nalamada; Srikant K Sahu; Sujata Das; Prashant Garg
Journal:  Indian J Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 1.848
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.